Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 3,500 peer-reviewed publications. The CPRD bibliography listed below is updated on a monthly basis (last updated 5 December 2024).

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: CPRD bibliography PDF December 2024 (PDF, 4.5MB, 330 pages) 

You can also export this list in BibTeX, EndNote, or other formats here.  

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

Page last reviewed
Year Sort ascending Title
2024

Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors

10.1016/j.jad.2024.01.163

Authors: J. Engler, C. Filliter, F. Montastruc, H. Abenhaim, S. Rej, C. Renoux

2024

Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020

10.1136/openhrt-2023-002515

Authors: J. Liaw, D. Liaw, C. Dave

2024

Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study

10.1136/heartjnl-2023-323577

Authors: J. Cuthbert, I. Soyiri, S. Lomax, J. Turgoose, A. Fuat, J. Cohen, A. Clark

2024

Post-hospitalisation asthma management in primary care: a retrospective cohort study

10.3399/bjgp.2023.0214

Authors: D. Punyadasa, N. Simms-Williams, N. Adderley, R. Thayakaran, A. Mansur, K. Nirantharakumar, P. Nagakumar, S. Haroon

2024

Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021

10.1007/s00415-023-12165-4

Authors: R. Shankar, X. Marston, V. Danielson, Do Rego, R. Lasagne, O. Williams, L. Groves

2024

Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study

10.1111/dom.15627

Authors: J. Dimakos, Y. Cui, R. Platt, C. Renoux, K. Filion, A. Douros

2024

Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study

10.1186/s12890-024-03035-4

Authors: E. Graul, C. Nordon, K. Rhodes, S. Menon, Al Ammouri, C. Kallis, A. Ioannides, H. Whittaker, N. Peters, J. Quint

2024

Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study

10.1136/bmj-2023-078523

Authors: N. Conrad, G. Molenberghs, G. Verbeke, F. Zaccardi, C. Lawson, J. Friday, H. Su, P. Jhund, N. Sattar, K. Rahimi, J. Cleland, K. Khunti, W. Budts, J. McMurray

2024

The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis

10.2147/clep.s463160

Authors: N. Barclay, T. Burkard, E. Burn, A. Delmestri, Miquel Dominguez, A. Golozar, C. Guarner-Argente, F. Avilés-Jurado, W . Y. Man, Roselló Serrano, A. Rosen, E. Tan, I. Tietzova, Prieto Alhambra, D. Newby

2024

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

10.1007/s40264-024-01434-4

Authors: S. Shapiro, H. Yin, O. H. Y. Yu, L. Azoulay

2024

Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study

10.1136/bmjgast-2024-001371

Authors: N. Jayasooriya, S. Saxena, J. Blackwell, A. Bottle, H. Creese, I. Petersen, R. Pollok

2024

Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink

10.1002/clc.24297

Authors: S. Kiddle, K. Sundell, S. Perl, S. Nolan, M. Bjursell

2024

Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibility

10.57264/cer-2023-0085

Authors: L. Zhang, J. Lewsey

2024

Prevalence, Incidence and Treatment Patterns of Prurigo Nodularis in England: A Retrospective Database Analysis

10.1093/bjd/ljae207

Authors: D. Bahloul, R. Hudson, O. Balogh, E. Mathias, B. Heywood, E. Hubbuck, O. Diribe, R. McDonald, A. Bewley

2024

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study

10.1177/17588359241253115

Authors: N. Barclay, M. Català, A. Jödicke, D. Prieto-Alhambra, D. Newby, A. Delmestri, W . Y. Man, Serrano À, M. Moncusí

2024

Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study

10.1136/thorax-2023-220887

Authors: R. Gupta, A. Morgan, P. George, J. Quint

2024

Use of cholesterol-lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink

10.1002/cncr.35436

Authors: S. Zamani, B. Graubard, M. Hyer, E. Carver, J. Petrick, K. McGlynn

2024

Using Routinely Collected Electronic Healthcare Record Data to Investigate Fibrotic Multimorbidity in England

10.2147/clep.s463499

Authors: G. Massen, H. Whittaker, S. Cook, G. Jenkins, R. Allen, L. Wain, I. Stewart, J. Quint

2024

Predicting type 1 diabetes in children using electronic health records in primary care in the UK: development and validation of a machine-learning algorithm

10.1016/s2589-7500(24)00050-5

Authors: R. Daniel, H. Jones, J. Gregory, A. Shetty, N. Francis, S. Paranjothy, J. Townson

2024

Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK

10.1183/23120541.00430-2023

Authors: J. Hwee, L. Harper, Q. Fu, K. Nirantharakumar, G. Mu, R. Jakes

2024

"Application of five different strategies to define a cohort of patients with knee osteoarthritis in a large primary care database"

10.1111/jep.14045

Authors: A. Taqi, S. Gran, R. Knaggs

2024

Potential interactions between medications for rate control and direct oral anticoagulants: population-based cohort and case-crossover study

10.1016/j.hrthm.2024.06.033

Authors: A . Y. Wong, C. Warren-Gash, K. Bhaskaran, C. Leyrat, A. Banerjee, L. Smeeth, I. Douglas

2024

Underlying disease risk among fatigued patients: a population-based cohort study in primary care

10.3399/bjgp.2024.0093

Authors: B. White, N. Zakkak, C. Renzi, M. Rafiq, A. Gonzalez-Izquierdo, S. Denaxas, B. Nicholson, G. Lyratzopoulos, M. Barclay

2024

Rising incidence, health resource utilization and costs of Polycystic Ovary Syndrome in the United Kingdom

10.1210/clinem/dgae518

Authors: T. Berni, C. Morgan, D. Rees

2024

Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)

10.1136/lupus-2024-001213

Authors: J. Ellis, N. McHugh, J. Pauling, I. Bruce, R. Charlton, A. McGrogan, S. Skeoch

2024

Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case-control study

10.1016/s2665-9913(24)00128-0

Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek

2024

Glucosamine and cancer incidence in osteoarthritis: A prevalent new-user cohort design

10.1002/acr.25399

Authors: K. Suissa, S. Dell'Aniello, E. Comin, M. Hudson, S. Suissa

2024

Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study

10.1371/journal.pmed.1004377

Authors: E. Powell, U. Gungabissoon, J. Tazare, L. Smeeth, P. Baptiste, T. Bin Hammad, A. Wong, I. Douglas, K. Wing

2024

Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study

10.1002/ehf2.14981

Authors: C. Ju, W. C. Y. Lau, C. Manisty, P. Chambers, R. Brauer, M. Forster, I. Mackenzie, L. Wei

2024

Respiratory Syncytial Virus Hospital Admission Rates and Patients' Characteristics Before the Age of 2 Years in England, 2015-2019

10.1097/inf.0000000000004467

Authors: M. Fonseca, S. Hagenaars, M. Bangert, C. Flach, R. Hudson

2024

Clinical and economic burden of severe asthma with low blood eosinophil counts

10.1016/j.jaip.2024.07.010

Authors: J. Busby, S. Menon, N. Martin, J. Lipworth, R. Zhang, H. Burhan, T. Brown, R. Chaudhuri, R. Gore, D. Jackson, S. Naveed, T. Pantin, P. Pfeffer, M. Patel, P. Patel, H. Rupani, L. Heaney

2024

Incidence, antimicrobial prescribing practice and associated healthcare costs of paediatric otorrhoea in primary care in the UK: A longitudinal population study

10.3399/bjgp.2024.0053

Authors: E. Heward, E. Domzaridou, S. Gavan, M. Carr, J. Lunn, J. Molloy, R. Isba, A. Hay, J. Nichani, I. Bruce, D. Ashcroft

2024

The long-term impact of vaginal surgical mesh devices on pain clinic and psychological service referrals, anti-inflammatory testing and pelvic scans in UK primary care: A cohort study with the Clinical Practice Research Datalink

10.1111/1471-0528.17828

Authors: E. McFadden, C. Heneghan

2024

Association of ethnicity and socioeconomic status with health outcomes in women with gestational diabetes: Clinical practice research datalink cohort study

10.1016/j.dsx.2024.103010

Authors: E. Vounzoulaki, J. Miksza, F. Zaccardi, B. Tan, M. Davies, K. Khunti, C. Gillies

2024

Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular Events

10.1089/thy.2024.0227

Authors: O. H. Y. Yu, C. Filliter, K. Filion, R. Platt, R. Grad, C. Renoux

2024

External validation of a prognostic model to improve prediction of psychosis in primary care

10.3399/bjgp.2024.0017

Authors: S. Sullivan, D. Kounali, P. Lilford, R. Morris, D. Kessler, W. Hamilton, G. Lewis, I. Nazareth

2024

Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study

10.1136/bmj-2023-076268

Authors: P. Mok, M. Carr, B. Guthrie, D. Morales, A. Sheikh, R. Elliott, E. Camacho, T. Van Staa, A. Avery, D. Ashcroft

2024

Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years

10.1186/s12875-023-02242-y

Authors: D. Kernick, N. Kondori, A. Pain, J. Mount, C. Appel, M. Ranopa, T. Gulati

2024

Impact of moderate-to-high-suicide-intent in major depressive disorder: a retrospective cohort study on patient characteristics and healthcare resource utilisation in England

10.1186/s12888-024-05961-3

Authors: T. Denee, C. Kerr, S. Richards, N. Dennis, A. Foix-Colonier, C. Fischer, F. Larkin

2024

Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England

10.1016/j.jinf.2024.106235

Authors: H. Wang, T. Doran, M. Crooks, K. Khunti, M. Heightman, A. Gonzalez-Izquierdo, Qummer Arfeen, A. Loveless, A. Banerjee, C. Van Der Feltz-Cornelis

2024

The incidence of lung cancer amongst primary care chest radiograph referrals; an evaluation of national and local datasets within the UK

10.1093/bjr/tqae142

Authors: B. Bhartia, D. Baldwin, S. Bradley, M. Callister, I. Das, M. Evison, S. Grundy, J. Kaur, M. Kennedy, E. O'Dowd

2024

The association of type 2 diabetes-related characteristics with fracture risk at different sites

10.1111/dom.15884

Authors: V. van Hulten, P. Souverein, J. Starup-Linde, R. Viggers, O. Klungel, P. Vestergaard, Mcjg Brouwers, J. van den Bergh, J. Driessen

2024

Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events

10.1164/rccm.202402-0368OC

Authors: C. Bloom, F. Yang, R. Hubbard, A. Majeed, J. Wedzicha

2024

Excess health care use is significantly and persistently reduced following diagnosis of late-onset epilepsy

10.1111/epi.18105

Authors: M. Berglund, A. Gonzalez-Izquierdo, S. Denaxas, B. Lethebe, T. Sajobi, J. Engbers, S. Wiebe, C. Josephson

2024

Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations

10.1002/hec.4903

Authors: D. Lugo-Palacios, P. Bidulka, S. O'Neill, O. Carroll, A. Basu, A. Adler, K. DíazOrdaz, A. Briggs, R. Grieve

2024

Impact of co-resident health and living alone on risk of hospital admission for people with Parkinson's disease

10.1016/j.parkreldis.2024.107084

Authors: C. Brack, E. Tenison, E. Henderson, S. Makin, Y. Ben-Shlomo

2024

Risk of unintended consequences from lower antibiotic prescribing for respiratory tract infections in primary care

10.1016/j.jinf.2024.106255

Authors: J. Stimson, T. McKeever, E. Agnew, W. Lim, S. Royal, P. Myles, S. Evans, J. Robotham

2024

Healthcare utilisation and associated costs for methadone versus buprenorphine recipients: Examination of interlinked primary and secondary care electronic health records in England

10.1111/dar.13933

Authors: E. Domzaridou, T. Allen, M. Carr, T. Millar, R. Webb, D. Ashcroft

2024

Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description

10.1136/bmjopen-2023-073866

Authors: K. Andersen, L. McGrath, M. Reimbaeva, D. Mendes, J. Nguyen, K. Rai, T. Tritton, C. Tsang, D. Malhotra, J. Yang

2023

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis

10.3310/ctmd0148

Authors: N. Qureshi, B. Woods, Neves de Faria, Saramago Goncalves, E. Cox, Leonardi Bee, L. Condon, S. Weng, R. Akyea, B. Iyen, P. Roderick, S. Humphries, W. Rowlands, M. Watson, K. Haralambos, R. Kenny, D. Datta, Z. Miedzybrodzka, C. Byrne, J. Kai